59293-32-2 Usage
Uses
Used in Research and Development Laboratories:
Tetrahydro-3-furancarboxylic acid hydrazide is used as a chemical compound for its role in synthetic chemistry and medicinal chemistry. It is employed for the development of various bioactive molecules and pharmaceuticals, leveraging its reactivity and structural properties to create complex molecules.
Used in Pharmaceutical Development:
Tetrahydro-3-furancarboxylic acid hydrazide is used as a building block in the synthesis of pharmaceuticals. Its reactivity allows for the creation of new compounds with potential therapeutic applications, contributing to the advancement of drug discovery and development.
Used in Synthetic Chemistry:
Tetrahydro-3-furancarboxylic acid hydrazide is used as a key intermediate in the synthesis of complex organic molecules. Its unique structure and reactivity make it a valuable component in the construction of a wide range of chemical compounds, facilitating the exploration of new chemical reactions and the creation of novel molecules with potential applications in various industries.
Check Digit Verification of cas no
The CAS Registry Mumber 59293-32-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,9,2,9 and 3 respectively; the second part has 2 digits, 3 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 59293-32:
(7*5)+(6*9)+(5*2)+(4*9)+(3*3)+(2*3)+(1*2)=152
152 % 10 = 2
So 59293-32-2 is a valid CAS Registry Number.
InChI:InChI=1/C5H10N2O2/c6-7-5(8)4-1-2-9-3-4/h4H,1-3,6H2,(H,7,8)
59293-32-2Relevant academic research and scientific papers
ANTIBIOTIC COMPOUNDS
-
Page/Page column 217; 218; 219, (2018/03/25)
The present invention relates to antibiotic compounds of formula (I), to compositions containing these compounds and to methods of treating bacterial diseases and infections using the compounds. The compounds find application in the treatment of infection with, and diseases caused by, Gram-positive and/or Gram-negative bacteria, and in particular in the treatment of infection with, and diseases caused by, Neisseria gonorrhoeae.
HETEROCYCLIC TRIAZOLE COMPOUNDS AS AGONISTS OF THE APJ RECEPTOR
-
Paragraph 1099; 1202, (2017/12/01)
Compounds of Formula I and Formula II, pharmaceutically acceptable salts thereof, stereoisomers of any of the foregoing, or mixtures thereof are agonists of the APJ Receptor and may have use in treating cardiovascular and other conditions. Compounds of Formula I and Formula II have the following structures: where the definitions of the variables are provided herein.
